HEATHER YATES-DAVIS: Open Payments
NPI 1811964398 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,905 in 104 payments from 19 companies in 2025. Trend: 2023 $1,599 · 2024 $1,979 · 2025 $1,905
Food & beverage: $1,905
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $427 |
| ABBVIE INC. | 36 | $415 |
| AstraZeneca Pharmaceuticals LP | 3 | $235 |
| Phathom Pharmaceuticals, Inc. | 6 | $192 |
| PFIZER INC. | 16 | $190 |
| Lilly USA, LLC | 9 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Ardelyx, Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: VRAYLAR, Ozempic, Wegovy, VOQUEZNA, NURTEC ODT, BREZTRI, MOUNJARO, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
